Detailed information for compound 161977

Basic information

Technical information
  • TDR Targets ID: 161977
  • Name: N-[9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1, 5-c]quinazolin-5-yl]-3-phenylpropanamide
  • MW: 417.848 | Formula: C22H16ClN5O2
  • H donors: 1 H acceptors: 4 LogP: 4.23 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)CCc1ccccc1
  • InChi: 1S/C22H16ClN5O2/c23-15-9-10-17-16(13-15)21-26-20(18-7-4-12-30-18)27-28(21)22(24-17)25-19(29)11-8-14-5-2-1-3-6-14/h1-7,9-10,12-13H,8,11H2,(H,24,25,29)
  • InChiKey: PMFILAFCPCLAGX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[9-chloro-2-(2-furyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-3-phenyl-propanamide
  • N-[9-chloro-2-(2-furyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-3-phenylpropanamide
  • N-[9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-3-phenyl-propanamide
  • N-[9-chloro-2-(2-furyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-3-phenyl-propionamide
  • N-(9-chloro-2-furan-2-yl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-3-phenylpropanamide
  • N-(9-chloro-2-furan-2-yl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-3-phenyl-propanamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Adenosine A2a receptor Starlite/ChEMBL References
Homo sapiens adenosine A3 receptor Starlite/ChEMBL References
Rattus norvegicus Adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 311 aa 21.2 %
Loa Loa (eye worm) hypothetical protein Adenosine A1 receptor   326 aa 300 aa 24.3 %
Schistosoma japonicum Alpha-1A adrenergic receptor, putative Adenosine A1 receptor   326 aa 295 aa 28.1 %
Echinococcus multilocularis neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %
Echinococcus granulosus neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 306 aa 21.2 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 337 aa 23.1 %
Echinococcus granulosus allatostatin A receptor Adenosine A2a receptor   410 aa 368 aa 22.6 %
Echinococcus multilocularis allatostatin A receptor Adenosine A2a receptor   410 aa 372 aa 22.8 %
Schistosoma mansoni dro/myosuppressin receptor Adenosine A1 receptor   326 aa 326 aa 22.1 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Adenosine A2a receptor   410 aa 346 aa 28.3 %
Schistosoma mansoni peptide (allatostatin)-like receptor Adenosine A1 receptor   326 aa 327 aa 24.8 %
Brugia malayi hypothetical protein Adenosine A1 receptor   326 aa 305 aa 21.0 %
Echinococcus granulosus thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 304 aa 21.1 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 356 aa 23.9 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 274 aa 22.6 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Adenosine A2a receptor   410 aa 366 aa 25.4 %
Loa Loa (eye worm) neuropeptide F receptor Adenosine A1 receptor   326 aa 316 aa 19.9 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 323 aa 20.7 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Adenosine A2a receptor   410 aa 340 aa 27.9 %
Onchocerca volvulus Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog Adenosine A1 receptor   326 aa 286 aa 22.7 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Adenosine A1 receptor   326 aa 317 aa 24.6 %
Schistosoma japonicum 5-hydroxytryptamine receptor 4, putative Adenosine A1 receptor   326 aa 286 aa 26.9 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A2a receptor   410 aa 352 aa 23.6 %
Schistosoma mansoni biogenic amine (5HT) receptor Adenosine A2a receptor   410 aa 399 aa 28.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis ubiquitin conjugating enzyme E2 N 0.008 1 1
Brugia malayi RNA binding protein 0.0072 0.8758 0.8758
Schistosoma mansoni tar DNA-binding protein 0.0072 0.8758 0.8758
Schistosoma mansoni tar DNA-binding protein 0.0072 0.8758 0.8758
Trypanosoma cruzi ubiquitin-conjugating enzyme E2, putative 0.008 1 1
Schistosoma mansoni tar DNA-binding protein 0.0072 0.8758 0.8758
Brugia malayi ubiquitin conjugating enzyme protein 13 0.008 1 1
Trypanosoma cruzi ubiquitin-conjugating enzyme E2, putative 0.008 1 1
Schistosoma mansoni tar DNA-binding protein 0.0072 0.8758 0.8758
Plasmodium falciparum ubiquitin-conjugating enzyme E2 N, putative 0.008 1 1
Loa Loa (eye worm) ubiquitin conjugating enzyme protein 13 0.008 1 1
Entamoeba histolytica ubiquitin-conjugating enzyme family protein 0.008 1 0.5
Trichomonas vaginalis ubiquitin-conjugating enzyme E2, putative 0.008 1 0.5
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0072 0.8758 0.8758
Echinococcus granulosus ubiquitin conjugating enzyme E2 N 0.008 1 1
Loa Loa (eye worm) RNA binding protein 0.0072 0.8758 0.8758
Echinococcus multilocularis tar DNA binding protein 0.0072 0.8758 0.8758
Loa Loa (eye worm) TAR-binding protein 0.0072 0.8758 0.8758
Brugia malayi TAR-binding protein 0.0072 0.8758 0.8758
Plasmodium vivax ubiquitin-conjugating enzyme E2 N, putative 0.008 1 1
Trypanosoma brucei ubiquitin-protein ligase, putative 0.008 1 1
Brugia malayi RNA recognition motif domain containing protein 0.0072 0.8758 0.8758
Echinococcus granulosus tar DNA binding protein 0.0072 0.8758 0.8758
Trichomonas vaginalis ubiquitin-conjugating enzyme E2, putative 0.008 1 0.5
Schistosoma mansoni ubiquitin conjugating enzyme 13 0.008 1 1
Schistosoma mansoni tar DNA-binding protein 0.0072 0.8758 0.8758
Toxoplasma gondii ubiquitin-conjugating enzyme subfamily protein 0.008 1 1
Leishmania major ubiquitin-conjugating enzyme e2, putative 0.008 1 1
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0018 0 0.5
Loa Loa (eye worm) ubiquitin conjugating enzyme protein 13 0.008 1 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 43 % Inhibition at 50 uM on cAMP production induced by 50 uM 5`-(N-ethylcarboxamido)adenosine in CHO cell line transfected with human Adenosine A2B receptor cDNA ChEMBL. 9667972
Inhibition (binding) = 43 % Inhibition at 50 uM on cAMP production induced by 50 uM 5`-(N-ethylcarboxamido)adenosine in CHO cell line transfected with human Adenosine A2B receptor cDNA ChEMBL. 9667972
Ki (binding) = 23.6 nM Binding affinity at cloned human adenosine A3 receptor expressed in HEK-293 cells was determined using [125I]-AB-MECA as radioligand ChEMBL. 9667972
Ki (binding) = 23.6 nM Binding affinity at cloned human adenosine A3 receptor expressed in HEK-293 cells was determined using [125I]-AB-MECA as radioligand ChEMBL. 9667972
Ki (binding) = 28.3 nM Binding affinity was determined in radioligand binding assay at rat striatal Adenosine A2A receptor vs [3H]-CGS- 21680 ChEMBL. 9667972
Ki (binding) = 28.3 nM Binding affinity was determined in radioligand binding assay at rat striatal Adenosine A2A receptor vs [3H]-CGS- 21680 ChEMBL. 9667972
Ki (binding) = 45.2 nM Binding affinity was determined in radioligand binding assay at rat brain adenosine A1 receptor vs [3H]-R-PIA ChEMBL. 9667972
Ki (binding) = 45.2 nM Binding affinity was determined in radioligand binding assay at rat brain adenosine A1 receptor vs [3H]-R-PIA ChEMBL. 9667972
Selectivity ratio (binding) = 1.6 Ratio against rat A2A receptor and Human A3 receptor ChEMBL. 9667972
Selectivity ratio (binding) = 1.9 Ratio against rat A1 receptor and Human A3 receptor ChEMBL. 9667972

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.